Showing 23,034 results

Filters Content type: Editors' picks
Ageing & HIV

New Lancet Initiative Seeks to Support Patients Living With HIV as They Age

Editor's pick
TheBodyPro
12 August 2026
Ageing & HIV

Low Testosterone Predicts Increased Frailty Risk in Older Men With HIV

Editor's pick
Infectious Disease Advisor
12 August 2026
People who inject drugs

Harm reduction makes uneven progress in Tanzania

Editor's pick
The Lancet HIV (requires free registration)
11 August 2026
Human rights

HIV care suffers under Senegal anti-gay law

Editor's pick
The Lancet (requires free registration)
10 August 2026
PrEP programmes & uptake

Nigeria’s Lenacapavir Rollout Needs a Safe Pharmacy Delivery Pathway

Editor's pick
Nigeria Health Watch (Medium)
10 August 2026
Migrants, refugees & displaced people

No, 2 million doses of HIV medication have not gone uncollected since anti-migrant protests in South Africa

Editor's pick
Africa Check
10 August 2026
Finance & funding

What China’s expanded funding for HIV/Aids in Africa means as US cuts health aid

Editor's pick
South China Morning Post
10 August 2026
Government, leadership & policy

Russia Says Its HIV Rates Are Falling. Experts Aren’t So Sure.

Editor's pick
The Moscow Times
10 August 2026
HIV testing programmes & uptake

US: Appalachian Country Music Festival Provided HIV, Hepatitis C Testing Outreach Opportunity

Editor's pick
Medscape (requires free registration)
10 August 2026
Exposure to HIV through medical procedures

Pakistan’s HIV Surge Exposes Infection Control Failures at Health Facilities

Editor's pick
Health Policy Watch
10 August 2026
People & personal stories

‘The boy who wanted a cure’: How Kenyan scientist became a global HIV leader

Editor's pick
Daily Nation
6 August 2026
New & experimental HIV treatments

AIDS 2026: ART pipeline and new drugs

Editor's pick
i-Base
5 August 2026
Injectable & long-acting PrEP

Cabotegravir HIV PrEP Effective Among U.S. Women Despite Treatment Interruptions

Editor's pick
MedPage Today (requires free registration)
5 August 2026
Heterosexual men

Mobile Men study: injectable PrEP beats pills for men who travel for work

Editor's pick
Africa Health Research Institute
5 August 2026
Access to healthcare

Lenacapavir, the revolutionary HIV drug, still hasn’t reached Latin America

Editor's pick
El País
5 August 2026
Antibody-based prevention

As a weekly anti-HIV pill nears the market, vaccine research faces new hurdles

Editor's pick
Science
5 August 2026
Migrants, refugees & displaced people

Zimbabweans Fleeing Xenophobia in South Africa Battle to Get HIV Medicine Back Home

Editor's pick
Health Policy Watch
5 August 2026
Injectable & long-acting PrEP

Gilead’s HIV PrEP franchise hits $1B quarterly sales, but analysts question Yeztugo durability

Editor's pick
FiercePharma
5 August 2026
Access to healthcare

South Africa: Some pieces falling into place for monthly HIV prevention pill, but key data not yet in

Editor's pick
Spotlight
2 August 2026
Access to healthcare

Why is Latin America still waiting for long-acting HIV prevention?

Editor's pick
Devex (requires free registration)
2 August 2026
HIV & criminal law

New data presented at AIDS 2026 reveal renewed rise in HIV criminalisation amid global anti-rights backlash

Editor's pick
HIV Justice Network
2 August 2026
HIV & criminal law

New research identifies how healthcare systems become gateways to HIV criminalisation

Editor's pick
HIV Justice Network
2 August 2026
Access to healthcare

Brazil: MSF at AIDS 2026 demanding affordable access to lenacapavir everywhere

Editor's pick
Médecins Sans Frontières
2 August 2026
Finance & funding

Global Activists Protest French Ambassador for Global Health Anne-Claire Amprou at the 26th International AIDS Conference

Editor's pick
Health GAP (Global Access Project)
2 August 2026